Journal of Medicinal Chemistry p. 714 - 717 (1985)
Update date:2022-08-05
Topics:
Miyano, Seiji
Sumoto, Kunihiro
Satoh, Fumio
Shima, Keiyu
Hayashimatsu, Mariko
et al.
The synthesis and antiarrhytmic activity of N-aryl-8-pyrrolizidinealkanamides are described.The targed compounds were evaluated for their ability to protect against chloroform-induced fibrillation in mice.Many of them were found to have antifibrillatory activity comparable to that of lidocaine; several are more potent than lidocaine.N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide (6n), which was found to be more potent and less toxic (LD50) than lidocaine, also showed a long duration of action in dogs with venticular arrhythmias after oral administration.
View MoreShanghai SMEC Trading Co., Ltd.
website:http://www.shanghaismec.com
Contact:+86-21-68811293
Address:ROOM 1101,NO.800 SHANGCHENG RD,SHANGHAI,CHINA
Zhejiang Hoshine Silicon Industry Co., Ltd.
Contact:86-573-89179966
Address:Zhapu Town, Pinghu City, Zhejiang, China
CGeneTech (Suzhou, China) Co., Ltd.
Contact:+86-512-62956962
Address:Room 101，Bld C11,218 Xinghu Rd.,Suzhou industrial Park
website:https://www.yurisolar.com/en
Contact:86--18092602675
Address:No. 560, East Hangtian Road, Xi'an, China
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
Doi:10.1055/s-0035-1560639
(2016)Doi:10.1021/ja0578956
(2006)Doi:10.1007/BF01552444
(1928)Doi:10.1016/0008-6215(83)88407-9
(1983)Doi:10.1002/hlca.19860690817
(1986)Doi:10.1016/j.bmcl.2007.05.087
(2007)
